Does post-procedural glycemic variability increase the risk of major complications in patients undergoing transcatheter aortic valve implantation?
Post-procedural glycemic variability is associated with an increased risk of short-term major complications following transcatheter aortic valve implantation.
This study showed that post-procedural glycemic variability was associated with an increased risk of major complications within 30 days after transcatheter aortic valve implantation. Trial registration Clinical trial registration number https://www.clinicaltrials.gov/ ; identifier: NCT02726958; date: April 4th, 2016.
Besch et al. (Mon,) studied this question.